Medican Enterprises, Inc.

MDCN

US58464T2024

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 03:18:22 2024-04-23 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2021	Medican Enterprises, Inc. acquired an unknown stake in Equity Apple, Inc.	CI
2021	Medican Enterprises, Inc. acquired 49% stake in R & B Property Development LLC.	CI

Medican Enterprises, Inc. acquired an unknown stake in Equity Apple, Inc.

August 23, 2021

Medican Enterprises, Inc. (OTCPK:MDCN) acquired an unknown stake in Equity Apple, Inc. on August 24, 2021. Medican Enterprises, Inc. (OTCPK:MDCN) completed the acquisition of an unknown stake in Equity Apple, Inc. on August 24, 2021.

Latest news about Medican Enterprises, Inc.

Medican Enterprises, Inc. acquired an unknown stake in Equity Apple, Inc.	21-08-23	CI
Medican Enterprises, Inc. acquired 49% stake in R & B Property Development LLC.	21-06-27	CI
Medican Enterprises, Inc. cancelled the acquisition of Chuck's Vintage Inc.	19-06-20	CI
Medican Enterprises, Inc. Announces Executive Change	19-04-04	CI
Medican Enterprises, Inc. acquired Chuck's Vintage Inc.	19-04-03	CI
The Now Corporation acquired majority assets of Medican Enterprises, Inc..	19-02-07	CI
Medican Enterprises, Inc. to Remove Ken Williams as Secretary and Director	15-10-07	CI
Medican Enterprises Enters into an Agreement with Music Quest Entertainment Studio	15-08-04	CI
Medican Enterprises, Inc. Signs Joint Venture with El Encanto Vineyards in Creating Newly Branded Moscato Wine	15-07-10	CI
Medican Enterprises, Inc. Accepts Resignation of Gary Johnson as Member of the Board of Directors	15-06-18	CI
Medican Enterprises, Inc. will Change its Ticker to MDCN from MDCND	15-05-15	CI
Medican Enterprises, Inc. (OTCPK:MDCN.D) completed the acquisition of TWYNS.	15-05-06	CI
Medican Enterprises, Inc. (OTCPK:MDCN.D) signed a definitive agreement to acquire TWYNS for $0.6 million.	15-04-28	CI
Medican Enterprises, Inc. will Change its Ticker to MDCND from MDCN	15-04-20	CI
Medican Enterprises Extends Closing On Two Phoenix Area Properties	15-04-18	CI
Medican Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	15-04-14	CI
Medican Enterprises Inc. Receives Zoning Approval for Marijuana Business Operations	15-02-25	CI
Medican Enterprises Buys 7,200 Sq. Ft. Retail and Commercial Property in Phoenix	15-01-23	CI
Medican Enterprises, Inc. announced that it has received $0.05 million in funding from RDW Capital, LLC.	15-01-15	CI
Medican Enterprises, Inc. announced that it has received $0.05 million in funding from KBM Worldwide, Inc.	15-01-15	CI
Medican Enterprises, Inc. announced that it expects to receive $0.05 million in funding from KBM Worldwide, Inc.	15-01-13	CI
Medican Enterprises, Inc. announced that it has received $0.0825 million in funding from Tangiers Investment Group LLC	14-12-08	CI
Medican to Launch Real Estate Leasing and Marijuana Services Business	14-12-02	CI
Medican Enterprises, Inc. Appoints Gary Johnson to its Board of Directors, Effective January 23, 2014	14-11-30	CI
Medican Enterprises, Inc. announced that it has received $0.04 million in funding from KBM Worldwide, Inc.	14-11-25	CI

Chart Medican Enterprises, Inc.

Duration

Period

More charts

Company Profile

Medican Enterprises, Inc. is engaged in residential and commercial real estate investment and development. The Company has relationships with equity suppliers, such as individual, commercial and institutional sources. The Company is specialized in value-added investment and development in A location in urban infill areas. The Companyâs subsidiary, Immediate Properties LLC, is a real estate company. Immediate Properties LLC is engaged in multifamily, retail, office, mixed-use, adaptive re-use of industrial buildings and historic renovations. Its investment portfolio includes properties across Northern and Southern California, Atlanta, and Nevada. The Company invests in California and other select metro areas.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MEDICAN ENTERPRISES, INC.	0.00%	38.94K
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals